4.5 Article

Evaluation of stability and inactivation methods of SARS-CoV-2 in context of laboratory settings

Journal

MEDICAL MICROBIOLOGY AND IMMUNOLOGY
Volume 210, Issue 4, Pages 235-244

Publisher

SPRINGER
DOI: 10.1007/s00430-021-00716-3

Keywords

SARS-CoV-2; COVID-19; Bio safety; Corona virus; Stability; Inactivation

Funding

  1. Goethe University & University Hospital Frankfurt
  2. Deutsche Forschungsgemeinschaft (DFG) [WI 5086/1-1]
  3. SARS-CoV-2 research

Ask authors/readers for more resources

The study evaluated the ability of commonly used lysis buffers in molecular biological laboratories to inactivate SARS-CoV-2, as well as analyzed viral stability in cell culture media and on display surfaces in a laboratory environment. Various chemical and non-chemical inactivation methods were also assessed, and it was found that certain detergent-containing lysis buffers were effective in inactivating the virus while others were not. Use of additional inactivation steps may be necessary before handling lysed viral samples from BSL-3.
The novel coronavirus SARS-CoV-2 is the causative agent of the acute respiratory disease COVID-19, which has become a global concern due to its rapid spread. Laboratory work with SARS-CoV-2 in a laboratory setting was rated to biosafety level 3 (BSL-3) biocontainment level. However, certain research applications in particular in molecular biology require incomplete denaturation of the proteins, which might cause safety issues handling contaminated samples. In this study, we evaluated lysis buffers that are commonly used in molecular biological laboratories for their ability to inactivate SARS-CoV-2. In addition, viral stability in cell culture media at 4 degrees C and on display glass and plastic surfaces used in laboratory environment was analyzed. Furthermore, we evaluated chemical and non-chemical inactivation methods including heat inactivation, UV-C light, addition of ethanol, acetone-methanol, and PFA, which might be used as a subsequent inactivation step in the case of insufficient inactivation. We infected susceptible Caco-2 and Vero cells with pre-treated SARS-CoV-2 and determined the tissue culture infection dose 50 (TCID50) using crystal violet staining and microscopy. In addition, lysates of infected cells and virus containing supernatant were subjected to RT-qPCR analysis. We have found that guanidine thiocyanate and most of the tested detergent containing lysis buffers were effective in inactivation of SARS-CoV-2, however, the M-PER lysis buffer containing a proprietary detergent failed to inactivate the virus. In conclusion, careful evaluation of the used inactivation methods is required especially for non-denaturing buffers. Additional inactivation steps might be necessary before removal of lysed viral samples from BSL-3.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available